Department of General, Visceral, Transplantation, Vascular, and Pediatric Surgery, University Hospital Wuerzburg, Wuerzburg, Germany.
Department of Gastroenterology, University Hospital Wuerzburg, Wuerzburg, Germany.
Surg Obes Relat Dis. 2023 Sep;19(9):1041-1048. doi: 10.1016/j.soard.2023.02.010. Epub 2023 Feb 15.
Gastric (anastomotic or staple-line) leaks after bariatric surgery are rare but potentially life-threatening complications. Endoscopic vacuum therapy (EVT) has evolved as the most promising treatment strategy for leaks associated with upper gastrointestinal surgery.
The aim of this study was to evaluate the efficiency of our gastric leak management protocol in all bariatric patients over a 10-year period. Special emphasis was placed on EVT treatment and its outcome as a primary treatment or as a secondary treatment when other approaches failed.
This study was performed at a tertiary clinic and certified center of reference for bariatric surgery.
In this retrospective single-center cohort study, clinical outcomes of all consecutive patients after bariatric surgery from 2012 to 2021 are reported, with special emphasis placed on gastric leak treatment. The primary endpoint was successful leak closure. Secondary endpoints were overall complications (Clavien-Dindo classification) and length of stay.
A total of 1046 patients underwent primary or revisional bariatric surgery, of whom 10 (1.0%) developed a postoperative gastric leak. Additionally, 7 patients were transferred for leak management after external bariatric surgery. Of these, 9 patients underwent primary and 8 patients underwent secondary EVT after futile surgical or endoscopic leak management. The efficacy of EVT was 100%, and there were no deaths. Complications did not differ between primary EVT and secondary treatment of leaks. Length of treatment was 17 days for primary EVT versus 61 days for secondary EVT (P = .015).
EVT for gastric leaks after bariatric surgery led to rapid source control with a 100% success rate both as primary and secondary treatment. Early detection and primary EVT shortened treatment time and length of stay. This study underlines the potential of EVT as a first-line treatment strategy for gastric leaks after bariatric surgery.
减重手术后的胃(吻合口或吻合线)漏是罕见但潜在危及生命的并发症。内镜下真空治疗(EVT)已成为治疗上消化道手术后吻合口漏的最有前途的治疗策略。
本研究旨在评估我们的胃漏管理方案在 10 年内所有减重患者中的效率。特别强调 EVT 治疗及其作为主要治疗方法的疗效,以及在其他方法失败时作为二级治疗的效果。
本研究在一家三级诊所和减重手术认证参考中心进行。
在这项回顾性单中心队列研究中,报告了 2012 年至 2021 年所有连续接受减重手术后的患者的临床结果,特别强调胃漏的治疗。主要终点是成功关闭漏口。次要终点是总并发症(Clavien-Dindo 分类)和住院时间。
共有 1046 例患者接受了初次或再次减重手术,其中 10 例(1.0%)术后发生胃漏。此外,还有 7 例在外部减重手术后转来进行漏的管理。其中,9 例患者在无效的手术或内镜漏管理后进行了初次 EVT,8 例患者进行了二次 EVT。EVT 的疗效为 100%,无死亡病例。主要 EVT 和漏的二级治疗之间的并发症无差异。初次 EVT 的治疗时间为 17 天,而二级 EVT 的治疗时间为 61 天(P =.015)。
EVT 治疗减重手术后的胃漏可迅速控制源头,作为一级和二级治疗均有 100%的成功率。早期发现和初次 EVT 可缩短治疗时间和住院时间。本研究强调了 EVT 作为减重手术后胃漏的一线治疗策略的潜力。